Luohu of Shenzhen: A Magnet for Global Investments

Luohu of Shenzhen: A Magnet for Global Investments

SHENZHEN, China, Dec. 12, 2024 /PRNewswire/ -- Saint-Gobain Group, a global leader in lightweight and sustainable construction solutions, reinvested in the Luohu district of Shenzhen this year. The French industrial giant, listed among the Global...

NaaS Technology Maintains Strong ESG Momentum with '2' Rating and Improved Entity Score from Sustainable Fitch

NaaS Technology Maintains Strong ESG Momentum with '2' Rating and Improved Entity Score from Sustainable Fitch

BEIJING, Dec. 12, 2024 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"), the first U.S.-listed EV charging service company in China, today announced that Sustainable Fitch has affirmed its ESG Entity Rating of '2' and...

China Matters' Feature: How History Uncovers the Culture

China Matters' Feature: How History Uncovers the Culture

HANGZHOU, China, Dec. 12, 2024 /PRNewswire/ -- In the heart of Hangzhou, China, Liangzhu Ancient City, which boasts rich cultural heritage, stands as a testament to a sophisticated 5,000-year-old civilization. At the 2nd Liangzhu Forum, guests from...

JA Solar's DeepBlue 4.0 Pro Wins "Very Good" Rating from PV Magazine Module Test

JA Solar's DeepBlue 4.0 Pro Wins "Very Good" Rating from PV Magazine Module Test

BEIJING, Dec. 12, 2024 /PRNewswire/ -- JA Solar, a global leader in the PV industry, has recently earned an outstanding five-star "VERY GOOD" rating for its DeepBlue 4.0 Pro 2465mm*1134mm (72-cell) module in the latest "PV Magazine Module Test."...

More than 96,000 respond to the first Global Cinema Federation Movie-Goer survey - 'New Box Office records will continue to be set, as supply meets demand'

More than 96,000 respond to the first Global Cinema Federation Movie-Goer survey - 'New Box Office records will continue to be set, as supply meets demand'

Customers largely prefer watching movies in cinemas, only 5% would rather wait to watch on streaming Customers are seeking MORE action/adventures (59%) and comedies (53%) in cinemas SYDNEY, Dec. 12, 2024 /PRNewswire/ -- The Global Cinema Federation...

NO MAINTENANCE, ADDITIONAL RATE COSTS AMONG TOP PERKS HIGHLIGHTED BY RENTERS IN NEW SURVEY

NO MAINTENANCE, ADDITIONAL RATE COSTS AMONG TOP PERKS HIGHLIGHTED BY RENTERS IN NEW SURVEY

BRISBANE, Australia, Dec. 12, 2024 /PRNewswire/ -- Tenants have declared the perks that will keep them renting for up to another five years in a new survey conducted by Budget Direct Home Insurance. Top of the list is no maintenance costs, with 51.4...

Fintech Abu Dhabi Unites Global Tech Leaders, Reaffirms Abu Dhabi as a Hub for Financial Innovation

Fintech Abu Dhabi Unites Global Tech Leaders, Reaffirms Abu Dhabi as a Hub for Financial Innovation

ABU DHABI, UAE, Dec. 12, 2024 /PRNewswire/ -- Fintech Abu Dhabi returned for its highly anticipated eighth edition, reinforcing its status as the Middle East's biggest fintech festival. Part of Abu Dhabi Finance Week (ADFW), the flagship event...

Pilatus Biosciences Inc. Secures FDA Orphan Drug Designation for PLT012: A Breakthrough in Liver and Intrahepatic Bile Duct Cancer Treatment

Pilatus Biosciences Inc. Secures FDA Orphan Drug Designation for PLT012: A Breakthrough in Liver and Intrahepatic Bile Duct Cancer Treatment

DOVER, Del. and EPALINGES, Switzerland, Dec. 11, 2024 /PRNewswire/ -- Pilatus Biosciences Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its leading molecule, PLT012, for treating liver...

2024 Understanding China Conference Concludes Successfully: A New Path for Global Understanding of Chinese Modernization

2024 Understanding China Conference Concludes Successfully: A New Path for Global Understanding of Chinese Modernization

GUANGZHOU, China, Dec. 10, 2024 /PRNewswire/ -- The 2024 Understanding China International Conference concluded after three days of insightful discussions, bringing together political leaders, scholars, business executives, and representatives from...

Live from ASH 2024 | Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax in Combinations Demonstrates Potential Clinical Benefit in Patients with Prior Exposure to Venetoclax

Live from ASH 2024 | Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax in Combinations Demonstrates Potential Clinical Benefit in Patients with Prior Exposure to Venetoclax

ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for...

  • 1
  • 2
  • 3
  • 4
  • 5
  • menu
    menu